Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · IEX Real-Time Price · USD
1.350
0.00 (0.00%)
At close: Jul 2, 2024, 3:59 PM
1.320
-0.030 (-2.22%)
After-hours: Jul 2, 2024, 7:49 PM EDT
Milestone Pharmaceuticals Market Cap
Milestone Pharmaceuticals has a market cap or net worth of $71.90 million as of July 2, 2024. Its market cap has decreased by -31.59% in one year.
Market Cap
71.90M
Enterprise Value
34.93M
1-Year Change
-31.59%
Ranking
Category
Stock Price
$1.35
Market Cap Chart
Since May 9, 2019, Milestone Pharmaceuticals's market cap has decreased from $355.80M to $71.90M, a decrease of -79.79%. That is a compound annual growth rate of -26.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 71.40M | 27.73% |
| Dec 29, 2023 | 55.90M | -58.84% |
| Dec 30, 2022 | 135.80M | -30.61% |
| Dec 31, 2021 | 195.70M | -2.05% |
| Dec 31, 2020 | 199.80M | -49.04% |
| Dec 31, 2019 | 392.10M | 10.20% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Conduit Pharmaceuticals | 73.47M |
| Serina Therapeutics | 73.03M |
| CASI Pharmaceuticals | 72.37M |
| Eagle Pharmaceuticals | 71.82M |
| Leap Therapeutics | 71.55M |
| Anixa Biosciences | 71.05M |
| MediciNova | 70.63M |
| Marinus Pharmaceuticals | 70.31M |